BET Bromodomain Inhibition of <i>MYC</i> -Amplified Medulloblastoma

Pratiti Bandopadhayay(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Yoon‐Jae Cho(Broad Institute), William J. Gibson(Broad Institute), Brian T. Nguyen(Los Angeles Medical Center), Rameen Beroukhim(Broad Institute), Sara Bolin(Uppsala University), Samuel Cheshier(Primary Children's Hospital), Siddhartha S. Mitra(Center for Infectious Disease Research), Mark W. Kieran(Children Cancer Hospital), Sharareh Gholamin(Institut de génétique et de développement de Rennes), Yujie Tang(Shanghai Jiao Tong University), Robert J. Wechsler‐Reya(Columbia University Irving Medical Center), Fredrik J. Swartling(Uppsala University), Jun Qi(Georgia Institute of Technology), William A. Weiss(City College of San Francisco), Guillaume Bergthold(Roche (Switzerland)), Steven E. Schumacher(Broad Institute), Brenton R. Paolella(Broad Institute), Rhamy Zeid(C4 Therapeutics (United States)), Furong Yu(Broad Institute), Simone Schubert(Stanford University), Nujsaubnusi Vue(Broad Institute), Kun-Wei Liu, James E. Bradner(Novartis (China)), Sabran Masoud(Broad Institute)
Clinical Cancer Research
December 2, 2013
Cited by 354


Related Papers